<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Danazol therapy renders red cells resistant to osmotic lysis</dc:title>
  <dc:creator>AHN, Y. S</dc:creator>
  <dc:creator>FERNANDEZ, L. F</dc:creator>
  <dc:creator>KIM, C. I</dc:creator>
  <dc:creator>RAVINDRA MYLVAGANAM</dc:creator>
  <dc:creator>TEMPLE, J. D. JR</dc:creator>
  <dc:creator>CAYER, M. L</dc:creator>
  <dc:creator>HARRINGTON, W. J</dc:creator>
  <dc:contributor>American society for clinical investigation. Annual meeting (San Diego 1987)</dc:contributor>
  <dc:relation>The FASEB journal -- FASEB j, CODEN FAJOEC, ISSN 0892-6638, Vol. 3 (2) , pp. 157-162</dc:relation>
  <dc:relation>American society for clinical investigation. Annual meeting (San Diego 1987)</dc:relation>
  <dc:date>1989</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Conference Paper</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Federation of American Societies for Experimental Biology</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>29 ref</dc:format>
  <dc:subject xml:lang="fr">Androgène</dc:subject>
  <dc:subject xml:lang="fr">Chimiothérapie</dc:subject>
  <dc:subject xml:lang="fr">Danazol</dc:subject>
  <dc:subject xml:lang="fr">Erythrocyte</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">Hormone stéroïde sexuelle</dc:subject>
  <dc:subject xml:lang="fr">Hémopathie</dc:subject>
  <dc:subject xml:lang="fr">Membrane biologique</dc:subject>
  <dc:subject xml:lang="fr">Mécanisme action</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="en">Androgen</dc:subject>
  <dc:subject xml:lang="en">Chemotherapy</dc:subject>
  <dc:subject xml:lang="en">Danazol</dc:subject>
  <dc:subject xml:lang="en">Red blood cell</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">Sex steroid hormone</dc:subject>
  <dc:subject xml:lang="en">Hemopathy</dc:subject>
  <dc:subject xml:lang="en">Biomembrane</dc:subject>
  <dc:subject xml:lang="en">Mechanism of action</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="es">Andrógeno</dc:subject>
  <dc:subject xml:lang="es">Quimioterapia</dc:subject>
  <dc:subject xml:lang="es">Danazol</dc:subject>
  <dc:subject xml:lang="es">Eritrocito</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Hormona esteroide sexual</dc:subject>
  <dc:subject xml:lang="es">Hemopatía</dc:subject>
  <dc:subject xml:lang="es">Membrana biológica</dc:subject>
  <dc:subject xml:lang="es">Mecanismo acción</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject>002B02O: Hormones. Glandes endocrines / Hormones. Endocrine system</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 6915378</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>